tiprankstipranks
aTyr Pharma (ATYR)
NASDAQ:ATYR

aTyr Pharma (ATYR) Income Statement

1,791 Followers

aTyr Pharma Income Statement

Last quarter (Q1 2024), aTyr Pharma's total revenue was $235.00K, an increase of Infinity% from the same quarter last year. In Q1, aTyr Pharma's net income was $-15.49M. See aTyr Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 588.00K$ 353.00K$ 10.39M-$ 10.46M$ 422.00K
Cost of Revenue
------
Gross Profit
$ 588.00K$ 353.00K$ 10.39M---
Operating Expense
$ 59.36M$ 55.27M$ 56.79M$ -34.02M$ 26.37M$ 23.40M
Operating Income
$ -58.77M$ -54.92M$ -46.40M$ -34.02M$ -15.91M$ -22.98M
Net Non Operating Interest Income Expense
---$ 238.00K--
Other Income Expense
$ -4.84M$ -4.52M$ -1.06M-$ -319.00K$ -785.00K
Pretax Income
$ -53.93M$ -50.40M$ -45.34M$ -33.78M$ -16.23M$ -23.76M
Tax Provision
$ -2.17M$ -2.17M$ -380.00K$ -592.00K--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -53.89M$ -50.39M$ -45.34M$ -33.77M$ -16.22M$ -23.60M
Basic EPS
$ -1.59$ -0.94$ -1.60$ -1.77$ -1.77$ -7.03
Diluted EPS
$ -1.59$ -0.94$ -1.60$ -1.77$ -1.77$ -7.03
Basic Average Shares
$ 238.61M$ 53.61M$ 28.42M$ 19.08M$ 9.16M$ 3.36M
Diluted Average Shares
$ 238.61M$ 53.61M$ 28.42M$ 19.08M$ 9.16M$ 3.36M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 59.36M$ 55.27M$ 56.79M$ -34.02M$ 26.37M$ 23.40M
Net Income From Continuing And Discontinued Operation
$ -53.89M$ -50.39M$ -45.34M$ -33.77M$ -16.22M$ -23.60M
Normalized Income
$ -9.75M---$ -16.22M$ -23.60M
Interest Expense
------
EBIT
$ -57.55M$ -54.92M$ -46.40M$ -33.78M$ -15.91M$ -22.98M
EBITDA
$ -55.68M$ -52.18M$ -44.71M$ -32.08M$ -14.64M$ -21.61M
Currency in USD

aTyr Pharma Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis